Novosibirsk, Russia
Novel Software Systems is a prominent bioinformatics and biotech research and development company, specializing in scientific software development and biological Big Data analysis. With a team of over 40 highly qualified software developers, bioinformaticians, and biologists, the company operates from various departments in Moscow, Saint-Petersburg, and Novosibirsk in Russia. The company has established collaborations with major international corporations and scientific laboratories in USA, Europe, China, and Russia.
As a leading player in its field, Novel Software Systems is recognized for its products that are integral to the development of new-generation medicine. The company's expertise in biotechnology, information technology, life sciences, platforms, social media, and clean energy reflects its commitment to innovation and diversification.
With a foundation dating back to 2004, Novel Software Systems embodies stability, substantial potential, an inviting work environment, and extensive international connections. Although the specific details about the last investment and investors are currently undisclosed, the company's impressive track record and widespread influence position it as an attractive prospect for venture capital.
